nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—HBA1—forelimb—amyotrophic lateral sclerosis	0.0474	0.109	CbGeAlD
Mefloquine—HBA2—forelimb—amyotrophic lateral sclerosis	0.0435	0.0998	CbGeAlD
Mefloquine—HBA1—hindlimb—amyotrophic lateral sclerosis	0.0427	0.0978	CbGeAlD
Mefloquine—HBA2—hindlimb—amyotrophic lateral sclerosis	0.0392	0.0898	CbGeAlD
Mefloquine—HBA1—appendage—amyotrophic lateral sclerosis	0.0366	0.0839	CbGeAlD
Mefloquine—HBA2—appendage—amyotrophic lateral sclerosis	0.0336	0.077	CbGeAlD
Mefloquine—BCHE—diaphragm—amyotrophic lateral sclerosis	0.0209	0.048	CbGeAlD
Mefloquine—Haematocrit decreased—Riluzole—amyotrophic lateral sclerosis	0.0208	0.0613	CcSEcCtD
Mefloquine—HBA1—hindbrain—amyotrophic lateral sclerosis	0.0194	0.0445	CbGeAlD
Mefloquine—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0388	CcSEcCtD
Mefloquine—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0335	CcSEcCtD
Mefloquine—HBA2—embryo—amyotrophic lateral sclerosis	0.0112	0.0256	CbGeAlD
Mefloquine—HBA1—brainstem—amyotrophic lateral sclerosis	0.0111	0.0255	CbGeAlD
Mefloquine—ADORA1—nerve—amyotrophic lateral sclerosis	0.0107	0.0245	CbGeAlD
Mefloquine—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0306	CcSEcCtD
Mefloquine—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00823	0.0243	CcSEcCtD
Mefloquine—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00812	0.024	CcSEcCtD
Mefloquine—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00788	0.0233	CcSEcCtD
Mefloquine—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00773	0.0228	CcSEcCtD
Mefloquine—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00764	0.0226	CcSEcCtD
Mefloquine—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00726	0.0214	CcSEcCtD
Mefloquine—Coma—Riluzole—amyotrophic lateral sclerosis	0.00707	0.0209	CcSEcCtD
Mefloquine—HBA1—spinal cord—amyotrophic lateral sclerosis	0.00692	0.0159	CbGeAlD
Mefloquine—HBA2—spinal cord—amyotrophic lateral sclerosis	0.00636	0.0146	CbGeAlD
Mefloquine—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00628	0.0185	CcSEcCtD
Mefloquine—HBA1—nervous system—amyotrophic lateral sclerosis	0.00583	0.0134	CbGeAlD
Mefloquine—HBA1—central nervous system—amyotrophic lateral sclerosis	0.00562	0.0129	CbGeAlD
Mefloquine—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00553	0.0163	CcSEcCtD
Mefloquine—HBA1—cerebellum—amyotrophic lateral sclerosis	0.00549	0.0126	CbGeAlD
Mefloquine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00548	0.0162	CcSEcCtD
Mefloquine—HBA2—nervous system—amyotrophic lateral sclerosis	0.00536	0.0123	CbGeAlD
Mefloquine—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00532	0.0157	CcSEcCtD
Mefloquine—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00528	0.0156	CcSEcCtD
Mefloquine—HBA2—central nervous system—amyotrophic lateral sclerosis	0.00516	0.0118	CbGeAlD
Mefloquine—HBA2—cerebellum—amyotrophic lateral sclerosis	0.00504	0.0116	CbGeAlD
Mefloquine—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00495	0.0146	CcSEcCtD
Mefloquine—HBA1—brain—amyotrophic lateral sclerosis	0.00446	0.0102	CbGeAlD
Mefloquine—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00435	0.0128	CcSEcCtD
Mefloquine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00424	0.0125	CcSEcCtD
Mefloquine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00415	0.0122	CcSEcCtD
Mefloquine—HBA2—brain—amyotrophic lateral sclerosis	0.00409	0.00939	CbGeAlD
Mefloquine—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00409	0.0121	CcSEcCtD
Mefloquine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00404	0.0119	CcSEcCtD
Mefloquine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00395	0.0117	CcSEcCtD
Mefloquine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00386	0.0114	CcSEcCtD
Mefloquine—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00382	0.0113	CcSEcCtD
Mefloquine—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00367	0.0108	CcSEcCtD
Mefloquine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00363	0.0107	CcSEcCtD
Mefloquine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.0036	0.0106	CcSEcCtD
Mefloquine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00352	0.0104	CcSEcCtD
Mefloquine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0035	0.0103	CcSEcCtD
Mefloquine—Chills—Riluzole—amyotrophic lateral sclerosis	0.00348	0.0103	CcSEcCtD
Mefloquine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00343	0.0101	CcSEcCtD
Mefloquine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.0034	0.01	CcSEcCtD
Mefloquine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00338	0.00998	CcSEcCtD
Mefloquine—ADORA2A—spinal cord—amyotrophic lateral sclerosis	0.00331	0.00759	CbGeAlD
Mefloquine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00325	0.0096	CcSEcCtD
Mefloquine—ADORA1—medulla oblongata—amyotrophic lateral sclerosis	0.0032	0.00735	CbGeAlD
Mefloquine—ACHE—medulla oblongata—amyotrophic lateral sclerosis	0.00318	0.0073	CbGeAlD
Mefloquine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00317	0.00935	CcSEcCtD
Mefloquine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00926	CcSEcCtD
Mefloquine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00311	0.00917	CcSEcCtD
Mefloquine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00305	0.009	CcSEcCtD
Mefloquine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00897	CcSEcCtD
Mefloquine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00303	0.00895	CcSEcCtD
Mefloquine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00303	0.00893	CcSEcCtD
Mefloquine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00882	CcSEcCtD
Mefloquine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00877	CcSEcCtD
Mefloquine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00865	CcSEcCtD
Mefloquine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00862	CcSEcCtD
Mefloquine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00288	0.0085	CcSEcCtD
Mefloquine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00288	0.0085	CcSEcCtD
Mefloquine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00288	0.0085	CcSEcCtD
Mefloquine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00847	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00844	CcSEcCtD
Mefloquine—ADORA1—spinal cord—amyotrophic lateral sclerosis	0.00286	0.00655	CbGeAlD
Mefloquine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00284	0.0084	CcSEcCtD
Mefloquine—ACHE—spinal cord—amyotrophic lateral sclerosis	0.00284	0.00651	CbGeAlD
Mefloquine—ADORA2A—nervous system—amyotrophic lateral sclerosis	0.00279	0.00639	CbGeAlD
Mefloquine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00278	0.00821	CcSEcCtD
Mefloquine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00815	CcSEcCtD
Mefloquine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00815	CcSEcCtD
Mefloquine—Shock—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00801	CcSEcCtD
Mefloquine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00799	CcSEcCtD
Mefloquine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.0027	0.00798	CcSEcCtD
Mefloquine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00795	CcSEcCtD
Mefloquine—ADORA2A—central nervous system—amyotrophic lateral sclerosis	0.00268	0.00616	CbGeAlD
Mefloquine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00791	CcSEcCtD
Mefloquine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00787	CcSEcCtD
Mefloquine—ADORA2A—cerebellum—amyotrophic lateral sclerosis	0.00262	0.00602	CbGeAlD
Mefloquine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00259	0.00595	CbGeAlD
Mefloquine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00258	0.00761	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00742	CcSEcCtD
Mefloquine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.0025	0.00737	CcSEcCtD
Mefloquine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00731	CcSEcCtD
Mefloquine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00726	CcSEcCtD
Mefloquine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00724	CcSEcCtD
Mefloquine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00243	0.00717	CcSEcCtD
Mefloquine—ADORA1—nervous system—amyotrophic lateral sclerosis	0.00241	0.00552	CbGeAlD
Mefloquine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00708	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00703	CcSEcCtD
Mefloquine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00702	CcSEcCtD
Mefloquine—ADORA1—central nervous system—amyotrophic lateral sclerosis	0.00232	0.00531	CbGeAlD
Mefloquine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00671	CcSEcCtD
Mefloquine—ADORA1—cerebellum—amyotrophic lateral sclerosis	0.00227	0.00519	CbGeAlD
Mefloquine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00666	CcSEcCtD
Mefloquine—ACHE—cerebellum—amyotrophic lateral sclerosis	0.00225	0.00516	CbGeAlD
Mefloquine—BCHE—brainstem—amyotrophic lateral sclerosis	0.00224	0.00515	CbGeAlD
Mefloquine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00647	CcSEcCtD
Mefloquine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00218	0.00644	CcSEcCtD
Mefloquine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00218	0.00644	CcSEcCtD
Mefloquine—ADORA2A—brain—amyotrophic lateral sclerosis	0.00213	0.00489	CbGeAlD
Mefloquine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00203	0.006	CcSEcCtD
Mefloquine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00584	CcSEcCtD
Mefloquine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00576	CcSEcCtD
Mefloquine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00557	CcSEcCtD
Mefloquine—ADORA1—brain—amyotrophic lateral sclerosis	0.00184	0.00422	CbGeAlD
Mefloquine—ACHE—brain—amyotrophic lateral sclerosis	0.00183	0.00419	CbGeAlD
Mefloquine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00182	0.00539	CcSEcCtD
Mefloquine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00518	CcSEcCtD
Mefloquine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00514	CcSEcCtD
Mefloquine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00513	CcSEcCtD
Mefloquine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00173	0.0051	CcSEcCtD
Mefloquine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00484	CcSEcCtD
Mefloquine—CYP19A1—nervous system—amyotrophic lateral sclerosis	0.00163	0.00374	CbGeAlD
Mefloquine—CYP19A1—central nervous system—amyotrophic lateral sclerosis	0.00157	0.0036	CbGeAlD
Mefloquine—BCHE—medulla oblongata—amyotrophic lateral sclerosis	0.00156	0.00359	CbGeAlD
Mefloquine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00149	0.00341	CbGeAlD
Mefloquine—BCHE—spinal cord—amyotrophic lateral sclerosis	0.0014	0.0032	CbGeAlD
Mefloquine—CYP19A1—brain—amyotrophic lateral sclerosis	0.00125	0.00286	CbGeAlD
Mefloquine—BCHE—nervous system—amyotrophic lateral sclerosis	0.00118	0.0027	CbGeAlD
Mefloquine—ABCB1—embryo—amyotrophic lateral sclerosis	0.00117	0.00268	CbGeAlD
Mefloquine—BCHE—central nervous system—amyotrophic lateral sclerosis	0.00113	0.0026	CbGeAlD
Mefloquine—BCHE—cerebellum—amyotrophic lateral sclerosis	0.00111	0.00254	CbGeAlD
Mefloquine—BCHE—brain—amyotrophic lateral sclerosis	0.000899	0.00206	CbGeAlD
Mefloquine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000792	0.00182	CbGeAlD
Mefloquine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000779	0.00179	CbGeAlD
Mefloquine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000762	0.00175	CbGeAlD
Mefloquine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.00075	0.00172	CbGeAlD
Mefloquine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000746	0.00171	CbGeAlD
Mefloquine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000733	0.00168	CbGeAlD
Mefloquine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000665	0.00152	CbGeAlD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000618	0.00274	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000617	0.00274	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000609	0.0027	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.0006	0.00267	CbGpPWpGaD
Mefloquine—BCHE—Glycerophospholipid biosynthesis—PLA2G4A—amyotrophic lateral sclerosis	0.000599	0.00266	CbGpPWpGaD
Mefloquine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000595	0.00137	CbGeAlD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000588	0.00261	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000587	0.00261	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000582	0.00258	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000581	0.00258	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000581	0.00258	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000575	0.00255	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.000567	0.00252	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000567	0.00252	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000561	0.00249	CbGpPWpGaD
Mefloquine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.00056	0.00128	CbGeAlD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000558	0.00248	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—ATF1—amyotrophic lateral sclerosis	0.000556	0.00247	CbGpPWpGaD
Mefloquine—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000551	0.00245	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000541	0.0024	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00054	0.0024	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00054	0.0024	CbGpPWpGaD
Mefloquine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000539	0.00124	CbGeAlD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CASP9—amyotrophic lateral sclerosis	0.000529	0.00235	CbGpPWpGaD
Mefloquine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000527	0.00121	CbGeAlD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000525	0.00233	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—ATF1—amyotrophic lateral sclerosis	0.000523	0.00232	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000519	0.0023	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000519	0.0023	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000498	0.00221	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000494	0.00219	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000482	0.00214	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000482	0.00214	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.000482	0.00214	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000482	0.00214	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00048	0.00213	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00047	0.00209	CbGpPWpGaD
Mefloquine—ACHE—Peptide hormone metabolism—IGF1—amyotrophic lateral sclerosis	0.00047	0.00208	CbGpPWpGaD
Mefloquine—ACHE—Phospholipid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000469	0.00208	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—SQSTM1—amyotrophic lateral sclerosis	0.000456	0.00202	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—ERBB4—amyotrophic lateral sclerosis	0.000453	0.00201	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000449	0.00199	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000441	0.00196	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000439	0.00195	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.00043	0.00191	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00043	0.00191	CbGpPWpGaD
Mefloquine—ABCB1—brain—amyotrophic lateral sclerosis	0.000428	0.000982	CbGeAlD
Mefloquine—ADORA2A—Signaling by NGF—ATF1—amyotrophic lateral sclerosis	0.000427	0.0019	CbGpPWpGaD
Mefloquine—BCHE—Peptide hormone metabolism—IGF1—amyotrophic lateral sclerosis	0.000419	0.00186	CbGpPWpGaD
Mefloquine—BCHE—Phospholipid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000418	0.00186	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—CASP9—amyotrophic lateral sclerosis	0.000407	0.00181	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000403	0.00179	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000403	0.00179	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.000397	0.00176	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000396	0.00176	CbGpPWpGaD
Mefloquine—CYP19A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000393	0.00174	CbGpPWpGaD
Mefloquine—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000392	0.00174	CbGpPWpGaD
Mefloquine—CYP19A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000388	0.00172	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000379	0.00168	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000371	0.00165	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000364	0.00162	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000363	0.00161	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000361	0.0016	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00036	0.0016	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.000354	0.00157	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000349	0.00155	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—ERBB4—amyotrophic lateral sclerosis	0.000348	0.00155	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000344	0.00153	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000334	0.00149	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000334	0.00148	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000328	0.00146	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000328	0.00146	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.000319	0.00142	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000312	0.00139	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000306	0.00136	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000301	0.00134	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000301	0.00134	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—VAPA—amyotrophic lateral sclerosis	0.0003	0.00133	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000298	0.00132	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000292	0.0013	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000292	0.0013	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000284	0.00126	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000282	0.00125	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000281	0.00125	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000279	0.00124	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000277	0.00123	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000275	0.00122	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000275	0.00122	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000273	0.00121	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000269	0.0012	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000269	0.00119	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000267	0.00119	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000266	0.00118	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000266	0.00118	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000262	0.00116	CbGpPWpGaD
Mefloquine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000256	0.00114	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000256	0.00114	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000253	0.00112	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000253	0.00112	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000249	0.0011	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000249	0.0011	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000246	0.00109	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000243	0.00108	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000241	0.00107	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000241	0.00107	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—DAO—amyotrophic lateral sclerosis	0.000237	0.00105	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000234	0.00104	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000231	0.00102	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000229	0.00102	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000218	0.000967	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000217	0.000964	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—DAO—amyotrophic lateral sclerosis	0.000211	0.000938	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00021	0.000933	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.00021	0.000931	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.00021	0.000931	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000205	0.000911	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000204	0.000905	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000195	0.000868	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000189	0.00084	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000189	0.000838	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000189	0.000837	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000188	0.000835	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000187	0.000831	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000187	0.000829	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000185	0.000819	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00018	0.000797	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000178	0.00079	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000177	0.000785	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000175	0.000779	CbGpPWpGaD
Mefloquine—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000173	0.000768	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	0.000171	0.000761	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000168	0.000744	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.000167	0.000741	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GSR—amyotrophic lateral sclerosis	0.000166	0.000736	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000165	0.000733	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000165	0.000732	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000163	0.000726	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000162	0.00072	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000161	0.000713	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00016	0.000711	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000157	0.000698	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000154	0.000685	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000152	0.000676	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000151	0.00067	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.00015	0.000667	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000149	0.00066	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GSR—amyotrophic lateral sclerosis	0.000148	0.000656	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000146	0.000647	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000144	0.00064	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000143	0.000633	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000143	0.000633	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000142	0.000633	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	0.000142	0.000629	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000139	0.000616	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000136	0.000605	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000136	0.000604	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000135	0.000598	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000134	0.000597	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000134	0.000597	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000134	0.000597	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00013	0.000579	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000127	0.000563	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000126	0.000562	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000126	0.000562	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000125	0.000555	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000124	0.000551	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000123	0.000546	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000121	0.000539	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000121	0.000539	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000121	0.000538	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000119	0.000529	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000119	0.000528	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000116	0.000515	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000115	0.000509	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000114	0.000507	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000114	0.000507	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000114	0.000506	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000113	0.000503	CbGpPWpGaD
Mefloquine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000113	0.000502	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000113	0.0005	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000111	0.000492	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000107	0.000477	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000107	0.000475	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000105	0.000467	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000103	0.000458	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	9.79e-05	0.000435	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	9.72e-05	0.000432	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.69e-05	0.00043	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.18e-05	0.000408	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.11e-05	0.000405	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	8.87e-05	0.000394	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	8.87e-05	0.000394	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	8.79e-05	0.00039	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	8.79e-05	0.00039	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.74e-05	0.000388	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.51e-05	0.000378	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	8.23e-05	0.000366	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.05e-05	0.000358	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	8.04e-05	0.000357	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	7.91e-05	0.000351	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.82e-05	0.000347	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	7.82e-05	0.000347	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.59e-05	0.000337	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.5e-05	0.000333	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.48e-05	0.000332	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.47e-05	0.000332	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	7.37e-05	0.000327	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.31e-05	0.000325	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	7.21e-05	0.00032	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.04e-05	0.000312	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	7.03e-05	0.000312	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	6.99e-05	0.00031	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	6.8e-05	0.000302	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.72e-05	0.000298	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.72e-05	0.000298	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.53e-05	0.00029	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	6.35e-05	0.000282	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.22e-05	0.000276	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.2e-05	0.000275	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.18e-05	0.000274	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6e-05	0.000266	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	5.92e-05	0.000263	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.79e-05	0.000257	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	5.58e-05	0.000248	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—APOE—amyotrophic lateral sclerosis	5.53e-05	0.000246	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	5.28e-05	0.000234	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—APOE—amyotrophic lateral sclerosis	5.08e-05	0.000226	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—APOE—amyotrophic lateral sclerosis	4.93e-05	0.000219	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	4.82e-05	0.000214	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.78e-05	0.000212	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.77e-05	0.000212	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.51e-05	0.0002	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	4.44e-05	0.000197	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.05e-05	0.00018	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.79e-05	0.000168	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.68e-05	0.000163	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	3.65e-05	0.000162	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.48e-05	0.000155	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.48e-05	0.000154	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.38e-05	0.00015	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.18e-05	0.000141	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.12e-05	0.000139	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.06e-05	0.000136	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	3e-05	0.000133	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.93e-05	0.00013	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.76e-05	0.000122	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	2.41e-05	0.000107	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.36e-05	0.000105	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	2.27e-05	0.000101	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.96e-05	8.71e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.8e-05	8e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.65e-05	7.32e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.55e-05	6.9e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.48e-05	6.58e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.02e-05	4.51e-05	CbGpPWpGaD
